0 CHECKOUT

Cough, Cold and Allergy (Hay Fever) Remedies in Germany

  • ID: 342814
  • May 2015
  • Region: Europe, Germany
  • 34 Pages
  • Euromonitor International

FEATURED COMPANIES

  • Arzneimittel GmbH & Co
  • Dr Soldan GmbH
  • Krewel Meuselbach GmbH
  • Merck KGaA
  • Pharma GmbH & Co KG
  • Ricola AG
  • MORE

Sales of cough, cold and allergy (hay fever) remedies are directly dependent on weather conditions and the related occurrence of cough, cold or allergy symptoms. While the category posted a strong performance in 2013 due to the effects of a heavy cold and flu season, the mild weather conditions in early and late 2014 resulted in a significant drop in demand for cough and cold remedies. As a result, virtually all categories registered sharp volume and current value declines.

The Cough, Cold and Allergy (Hay Fever) Remedies in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arzneimittel GmbH & Co
  • Dr Soldan GmbH
  • Krewel Meuselbach GmbH
  • Merck KGaA
  • Pharma GmbH & Co KG
  • Ricola AG
  • MORE

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN GERMANY

May 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2009-2014
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2009-2014
Table 3 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2009-2014
Table 4 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2009-2014
Table 5 Sales of Decongestants by Category: Value 2009-2014
Table 6 Sales of Decongestants by Category: % Value Growth 2009-2014
Table 7 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2010-2014
Table 8 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2011-2014
Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2014-2019
Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2014-2019
Abtei Op Pharma GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 1 Abtei OP Pharma GmbH: Key Facts
Company Background
Competitive Positioning
Summary 2 Abtei OP Pharma GmbH: Competitive Position 2014
Bayer Vital GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 3 Bayer Vital GmbH: Key Facts
Company Background
Production
Summary 4 Bayer Vital GmbH: Production Statistics 2014
Competitive Positioning
Summary 5 Bayer Vital GmbH: Competitive Position 2014
Boehringer Ingelheim Pharma GmbH & Co Kg in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 6 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts
Summary 7 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators
Company Background
Production
Summary 8 Boehringer Ingelheim Pharma GmbH & Co KG: Production Statistics 2014
Competitive Positioning
Summary 9 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2014
Mcm Klosterfrau Vertriebsgesellschaft Mbh in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 10 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts
Company Background
Production
Competitive Positioning
Summary 11 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2014
Merck Selbstmedikation GmbH in Consumer Health (germany)
Strategic Direction
Key Facts
Summary 12 Merck Selbstmedikation GmbH: Key Facts
Company Background
Production
Competitive Positioning
Summary 13 Merck Selbstmedikation GmbH: Competitive Position 2014
Executive Summary
Consumer Health in Germany Hampered by Slump in OTC Sales
Consumer Health Remains A Fragmented Market, With No One Player Commanding More Than A Single-digit Value Share
Chemists/pharmacies Remains the Dominant Distribution Channel
Consumer Health Expected To Face Stagnation Over the Forecast Period
Key Trends and Developments
Milder Climate Brings Both Obstacles and Opportunities
Demographic Changes Have A Mixed Impact on Sales
Companies Make Use of Synergy Between Sports Nutrition and Slimming Products
Market Indicators
Table 11 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 12 Life Expectancy at Birth 2009-2014
Market Data
Table 13 Sales of Consumer Health by Category: Value 2009-2014
Table 14 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 15 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 16 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 17 Penetration of Private Label in Consumer Health by Category: % Value 2009-2014
Table 18 Distribution of Consumer Health by Format: % Value 2009-2014
Table 19 Distribution of Consumer Health by Format and Category: % Value 2014
Table 20 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 21 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 14 OTC: Switches 2012-2014
Definitions
Sources
Summary 15 Research Sources

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Arzneimittel GmbH & Co
  • Dr Soldan GmbH
  • Krewel Meuselbach GmbH
  • Merck KGaA
  • Pharma GmbH & Co KG
  • Ricola AG
  • MORE

Consumer attitudes towards self-medication
According to industry experts, three quarters of the German population over the age of 15 years old selfmedicate. It is estimated that around 50% of the population regularly use self-medication products for health maintenance and sickness prevention, making a considerable contribution to public health and alleviating pressure on the state healthcare budget.

Consumers’ income elasticity regarding preventive products (vitamins, minerals and natural mineral water, etc) is greater than that for therapeutic medicines in Germany. Knowledge about medicines is increasing all the time, forming a solid basis for the appropriate use of medicines for the purposes of self-medication. The majority of German consumers regard themselves as well informed about medicines. German consumers are typically able to ask for OTC products by name, and are showing increasing brand loyalty.

Note: Product cover images may vary from those shown

Companies Mentioned Include:
- Bayer Vital GmbH
- Novartis Consumer Health GmbH
- Boehringer Ingelheim
- Pharma GmbH & Co KG
- Beiersdorf AG
- Ratiopharm GmbH & Co
- Abtei Pharma Vertriebs-GmbH
- Procter & Gamble GmbH
- STADA Arzneimittel AG
- Whitehall Much GmbH
- Bayer Group (Bayer Vital GmbH)
- MCM Klosterfrau Vertriebgesellschaft mbH
- Mann Chem-Pharm Fabrik GmbH, Dr Gerhard
- Madaus AG
- Impuls-Vermarktung GmbH & Co KG
- Spitzner Arzneimittel GmbH
- Boots Healthcare Deutschland GmbH
- Roche Consumer Health Deutschland GmbH
- McNeil GmbH & Co
- Ricola AG
- Aventis Pharma Deutschland GmbH (Nattermann & Cie GmbH)
- Hexal AG
- Pfizer Consumer Healthcare GmbH
- Nattermann & Cie GmbH
- Johnson & Johnson GmbH
- Viatris GmbH & Co KG (formerly known as Asta Medica AG)
- Bad Heilbrunner Naturheilmittel GmbH & Co
- Gödecke AG
- Engelhard Arzneimittel GmbH and Co KG
- Solvay Arzneimittel GmbH
- Merck KGaA
- Lichtwer Pharma AG
- Dr Soldan GmbH
- Merz & Co GmbH & Co
- Milupa GmbH & Co KG
- Krewel Meuselbach GmbH
- Galenika Dr Hetterich GmbH
- Divapharma-Knufinke Arzneimittelwerk GmbH
- Pohl-Boskamp GmbH und Co
- Weleda AG
- Woelm Pharma GmbH & Co Dr Rentschler
- Arzneimittel GmbH & Co
- GlaxoSmithKline GmbH & Co KG
- Wolff GmbH & Co Arzneimittel, Dr August

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH